These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35231479)

  • 1. PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer.
    Chen Y; Ma X; Lou C; Zhou C; Zhao X; Li N; Tian H; Meng X
    Clin Chim Acta; 2022 May; 530():55-65. PubMed ID: 35231479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum exosomal hsa_circ_0069313 has a potential to diagnose more aggressive non-small cell lung cancer.
    Chen Y; Lou C; Ma X; Zhou C; Zhao X; Li N; Tian H; Meng X
    Clin Biochem; 2022 Apr; 102():56-64. PubMed ID: 35077682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer.
    Han P; Zhao J; Gao L
    J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal LncRNA RP5-977B1 as a novel minimally invasive biomarker for diagnosis and prognosis in non-small cell lung cancer.
    Min L; Zhu T; Lv B; An T; Zhang Q; Shang Y; Yu Z; Zheng L; Wang Q
    Int J Clin Oncol; 2022 Jun; 27(6):1013-1024. PubMed ID: 35482171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
    Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y
    Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mtDNA fragments within exosomes might be novel diagnostic biomarkers of non-small cell lung cancer.
    Lou C; Ma X; Chen Z; Zhao Y; Yao Q; Zhou C; Zhao X; Meng X
    Pathol Res Pract; 2023 Sep; 249():154718. PubMed ID: 37544132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Value of Serum Exosomal miR-184 in the Diagnosis of NSCLC.
    Li S; Lin Y; Wu Y; Chen H; Huang Z; Lin M; Dong J; Wang Y; Yang Z
    J Healthc Eng; 2022; 2022():9713218. PubMed ID: 35444778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
    Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Niu L; Song X; Wang N; Xue L; Song X; Xie L
    Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W; Liu J; Zhang Q; Wei L
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.
    Wang X; Jiang X; Li J; Wang J; Binang H; Shi S; Duan W; Zhao Y; Zhang Y
    Thorac Cancer; 2020 Dec; 11(12):3436-3447. PubMed ID: 33107700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma versican and plasma exosomal versican as potential diagnostic markers for non-small cell lung cancer.
    Chang W; Zhu J; Yang D; Shang A; Sun Z; Quan W; Li D
    Respir Res; 2023 May; 24(1):140. PubMed ID: 37259101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer.
    Dong Q; Dong L; Liu S; Kong Y; Zhang M; Wang X
    Med Sci Monit; 2020 Jun; 26():e923210. PubMed ID: 32502142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
    Xian J; Zeng Y; Chen S; Lu L; Liu L; Chen J; Rao B; Zhao Z; Liu J; Xie C; Zhu L; Zhang D; Qiu F; Lu J; Yang L
    Carcinogenesis; 2021 Jun; 42(6):831-841. PubMed ID: 33928340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-30 Play an Important Role in Non-Small Cell Lung Cancer (NSCLC).
    Sui JYAX
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.